TROP-2 and Nectin-4 Expression in Muscle-Invasive Urothelial and Rare Non-Urothelial Bladder Carcinoma: Association with Tumour Stage and Clinical Outcome.

Padcev (enfortumab vedotin-ejfv) - Astellas, Pfizer

Trodelvy (sacituzumab govitecan-hziy) - Gilead

http://www.ncbi.nlm.nih.gov/pubmed/42649895

Hossein Tezval; Jan H Bräsen; Jessica Schmitz; Markus A Kuczyk; Mohammed Rafea Kanaan; Pouriya Faraj Tabrizi

Aug 28, 2026